tirzepatide bogota colombia Mounjaro 12.5mg/0.5mL Injection Bogota, Colombia | World Gastroenterology
Description
Dehydration and electrolyte imbalances commonly accompany GLP-1 receptor agonist therapy, particularly when gastrointestinal side effects such as vomiting or diarrhoea are present
You may benefit from limiting coffee if you experience: Severe nausea or repeated vomiting Persistent acid reflux or stomach pain Poor sleep affecting recovery or daily energy Dizziness, headaches, or signs of dehydration Difficulty eating enough calories or fluids People experiencing ongoing digestive symptoms, dehydration, worsening reflux, or persistent discomfort should consider speaking with a GP or healthcare professional during treatment
This phase brings the most noticeable GI side effects for many women
[DOI] [PubMed] [Google Scholar] 309.Alsalim W., Lindgren O., Ahren B
In a meta-analysis of 12 randomised controlled trials by Cai et al, Tirzepatide could significantly reduce the body weight, BMI, and waist circumference in patients compared to GLP-1 receptor agonists, placebo, and insulin groups 1
doi: 10.1007/S12630-023-02440-3 109 FezzaRRainsBFezzaTFezzaJP
